As of September 2024 GlaxoSmithKline has a market cap of A$135.16 Billion. This makes GlaxoSmithKline the world's 188th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Sep 7th, 2024 the market cap of GlaxoSmithKline was reported to be: